Riverview Trust Company’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-394
Closed -$18K 774
2024
Q4
$18K Sell
394
-17
-4% -$761 0.02% 506
2024
Q3
$19.3K Sell
411
-213
-34% -$9.71K 0.02% 499
2024
Q2
$26.4K Hold
624
0.03% 347
2024
Q1
$27.6K Buy
+624
New +$28.4K 0.02% 362
2023
Q4
Sell
-624
Closed -$26.8K 507
2023
Q3
$26.8K Buy
+624
New +$29.1K 0.02% 325
2022
Q2
Sell
-378
Closed -$20K 832
2022
Q1
$20K Buy
+378
New +$19.5K 0.01% 498

Other funds holding QGEN

Riverview Trust Company's QGEN Position: Q1 2025 in Review

Riverview Trust Company sold out of Qiagen (QGEN) in Q1 2025, closing a stake of 394 shares — an estimated $18K sold.

Riverview Trust Company first reported a position in QGEN in Q1 2022 and held it in 6 quarters. The position peaked at $27.6K in Q1 2024. 298 funds tracked by Wall St. Rank hold QGEN as of Q1 2025.

  • Riverview Trust Company reported no remaining Qiagen position as of Q1 2025 after selling out during the quarter.
  • Riverview Trust Company sold 394 Qiagen shares in Q1 2025, an estimated $18K.
  • Riverview Trust Company first reported a position in Qiagen in Q1 2022 and held it in 6 quarters.
  • Riverview Trust Company's Qiagen position peaked at $27.6K in Q1 2024.
  • 298 funds tracked by Wall St. Rank held Qiagen as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.